We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effects of Mycobacterial Cell Wall-DNA Complex(MCC), Alendronate and Pamidronate on Canine Osteosarcoma Cell Lines.
- Authors
Filion, M. C.; Filion, B.; Phillips, N. C.
- Abstract
MCC, a cell wall composition prepared fromMycobacterium phlei., inhibits the proliferation and induces apoptosis in a wide range of tumor cells. Bisphosphonates have been reported to inhibit the proliferation of canine osteosarcoma cell lines. In this study, we have determined the activity of MCC alone and in combination with the bisphosphonates alendronate and pamidronate on canine osteosarcoma cell lines.Canine osteosarcoma cell lines D17 and D22 were incubated with different concentrations of MCC(0.01–100 μg/ml) and suboptimal concentrations of alendronate and pamidronate for 72 hours. Cellular proliferation was measured by MTT reduction. Nuclear DNA condensation was determined using with Hoescht 33258 staining, and apoptosis by flow cytometry using active-caspase-3/PE and anti-cleaved-PARP/FITC antibodies.MCC inhibited the proliferation of both canine osteosarcoma D17 and D22 cell lines in a concentration-dependent manner. The IC50 for D17 cells was 3.9 μg/ml and for D22 cells 44.4 μg/ml. Cells incubated with 100 μg/ml MCC were positive for Hoescht staining, active caspase-3 and cleaved PARP, indicative of cell death by apoptosis. The addition of alendronate or pamidronate was found to potentiate the apoptosis-inducing activity of MCC. Maximal activity was observed when 5 μM alendronante or 10 μM pamidronate were used in combination with 100 μg/ml MCC.MCC inhibits the proliferation and induces apoptosis in canine osteosarcoma cell linesin vitro. This anticancer activity can be potentiated by the use of alendronate and pamidronate. These data support the development of MCC as a therapeutic agent for the treatment of canine osteosarcoma.
- Subjects
MYCOBACTERIUM phlei; ATYPICAL mycobacteria; DNA; OSTEOSARCOMA; CANCER treatment; THERAPEUTICS
- Publication
Veterinary & Comparative Oncology, 2005, Vol 3, Issue 1, p35
- ISSN
1476-5810
- Publication type
Article
- DOI
10.1111/j.1476-5810.2005.0064f.x